Clinical Trials · NCT07635953
New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Sun Yat-sen University
- Enrollment
- 296
- Start date
- Jul 2026
- Locations
- 1 site, China
- Primary endpoint
- Diabetic remission rate